Company · CIK 0000897448 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AMARIN CORP PLC\UK · AMRN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 FMForm 4 → | Aug 3, 4:30 pm EDT | Peter L. FishmanSVP, CFO | 468 | $14.26 | $2,210 | 7,619 | — | |
| Jul 1, 2026 FMForm 4 → | Jul 15, 5:00 pm EDT | Peter L. FishmanSVP, CFO | 3,653 | $15.94 | $19,224 | 7,461 | — | late |
| Jul 1, 2026 FMForm 4 → | Jul 15, 5:00 pm EDT | David Paul KeenanEVP, Chief Operating Officer | 5,614 | $15.94 | $30,700 | 13,470 | — | late |
| Jul 1, 2026 FMForm 4 → | Jul 15, 5:00 pm EDT | Steven B KetchumEVP, Chief Scientific Officer | 5,575 | $15.94 | $30,079 | 42,680 | — | late |
| Jul 1, 2026 FMForm 4 → | Jul 15, 5:00 pm EDT | Jonathan ProvoostEVP, Chief Legal Officer | 4,952 | $15.94 | $20,148 | 4,624 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 AForm 4 → | Aug 3, 4:30 pm EDT | Peter L. FishmanSVP, CFO | 313 | — | — | 0 | — | |
| Jul 1, 2026 AForm 4 → | Jul 15, 5:00 pm EDT | Peter L. FishmanSVP, CFO | 2,447 | — | — | 0 | — | late |
| Jul 1, 2026 AForm 4 → | Jul 15, 5:00 pm EDT | David Paul KeenanEVP, Chief Operating Officer | 3,688 | — | — | 0 | — | late |
| Jul 1, 2026 AForm 4 → | Jul 15, 5:00 pm EDT | Steven B KetchumEVP, Chief Scientific Officer | 3,688 | — | — | 0 | — | late |
| Jul 1, 2026 AForm 4 → | Jul 15, 5:00 pm EDT | Jonathan ProvoostEVP, Chief Legal Officer | 3,688 | — | — | 0 | — | late |